Utility of a fusion protein T-cell co-stimulation blocker Belatacept in heart transplant recipients: Real world experience from a high volume center.
Oren D, Uriel M, Moeller CM, Valledor AF, DeFilippis EM, Lotan D, Colombo PC, Yuzefpolskaya M, Topkara VK, Clerkin KJ, Raikhelkar JK, Fried JA, Oh DKT, Bae D, Lin E, Theodoropoulos K, Naka Y, Takeda K, Choe J, Jennings DL, Majure D, Latif F, Sayer G, Uriel N.
Oren D, et al. Among authors: fried ja.
Clin Transplant. 2024 Mar;38(3):e15251. doi: 10.1111/ctr.15251.
Clin Transplant. 2024.
PMID: 38504576